Glucose metabolism
|
GLUT1/4 |
Glucose transporter 1/4 |
− |
Suppress transcription |
Inhibit glucose uptake and glycolysis |
− |
|
[19, 21, 22, 24] |
PON2 |
Paraoxonase 2 |
− |
Suppress transcription |
Inhibit glucose uptake and glycolysis |
− |
|
[22] |
RRAD |
Ras-related associated with diabetes |
+ |
Promote transcription |
Inhibit GLUT1 translocation to the plasma membrane to import glucose, thus inhibit glycolysis |
− |
|
[24] |
Lipid metabolism
|
GLUT3 |
Glucose transporter 3 |
− |
Inhibit nuclear factor-κB (NF-κB), which activates GLUT3 |
Inhibit glucose uptake and glycolysis |
− |
|
[23] |
GLUT12 (SLC2A12) |
Glucose transporter 12 (solute carrier family 2 member 12) |
− |
Suppress transcription |
Inhibit glucose uptake and glycolysis |
− |
|
[20] |
INSR (IR) |
Insulin receptor |
− |
Suppress transcription |
Inhibit glucose uptake and glycolysis |
− |
|
[25] |
HK1 and GPI |
HK1: hexokinase 1; GPI: glucose phosphate isomerase |
− |
Induce miR-34a to inhibit translation |
Inhibit glycolysis |
− |
|
[27] |
HK2 |
Hexokinase 2 |
+/− |
Activate TIGAR to promote its activity or induce miR-34a and miR-143 to inhibit its translation |
Lower ROS or inhibit glycolysis |
− |
ROS control |
[27, 28, 40] |
PGM |
Phosphoglycerate mutase |
+/− |
Promote transcription (in muscle) or suppress transcription (in fibroblast) or induce miR-34a to inhibit its translation |
Promote or inhibit glycolysis |
+/− |
|
[27, 29, 39] |
ENO3 |
β-enolase |
− |
Suppress transcription |
Inhibit glycolysis and lactate production |
NA |
|
[30] |
TIGAR |
TP53-induced glycolysis and apoptosis regulator |
+ |
Promote transcription |
Inhibit glycolysis to promote PPP or promote HK2 activity to lower ROS |
+ |
ROS control |
[31, 40] |
PFKFB3 |
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
− |
Suppress transcription |
Inhibit glycolysis but promote PPP |
− |
|
[32] |
PFKFB4 |
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
− |
Suppress transcription |
Promote glycolysis but inhibit PPP |
− |
|
[33] |
G6PDH |
Glucose-6-phosphate dehydrogenase |
− |
Bind to inhibit its activity |
Inhibit PPP |
− |
|
[34] |
MCT1 (SLC16A1) |
Monocarboxylate transporter 1 (solute carrier family 16 member 1) |
− |
Suppress transcription |
Inhibit lactate export and glycolysis |
− |
|
[37] |
G6PC |
Glucose-6-Phosphatase Catalytic Subunit |
+/− |
Promote expression or inhibit expression through activation of SIRT6 |
Promote or suppress glyconeogenesis |
−/+ |
|
[41, 43] |
PCK1 |
Phosphoenolpyruvate carboxykinase 1 |
− |
Inhibit expression through activation of SIRT6 |
Suppress glyconeogenesis |
+ |
|
[43] |
PCK2, GK, AQP3/9, and GOT1 |
PCK2: phosphoenolpyruvate carboxykinase 2; AQP3/9: aquaporin 3/9; GOT1: glutamic-oxaloacetic transaminase 1 |
+ |
Promote expression |
Promote glyconeogenesis |
− |
|
[41] |
GYS2 |
Glycogen synthase 2 |
− |
Suppress transcription |
Inhibit glycogen synthesis |
+ |
|
[44] |
FUCA1 |
Alpha-L-fucosidase 1 |
+ |
Promote transcription |
Promote chemotherapy-induced apoptosis |
− |
|
[47] |
PDK1 |
Pyruvate dehydrogenase kinase 1 |
− |
Induce miR-34a to inhibit translation |
Promote TCA cycle |
− |
|
[27] |
PDK2 |
Pyruvate dehydrogenase kinase 2 |
− |
Suppress transcription |
Promote TCA cycle |
− |
|
[48] |
PARK2 (Parkin) |
Parkinson disease 2 |
+/− |
Promote transcription or bind to suppress its activity |
(1) Promote TCA cycle (by enhance the expression of PDHA1--a component of PDH complex); (2) inhibit glycolysis (by suppress PKM2 and HIF1α); (3) positively regulate PTEN to lower ROS and repress the PI3K/AKT pathway; (4) promote OXPHOS with PINK1; (5) promote mitophagy to suppress ferroptosis |
− |
ROS control, autophagy, and ferroptosis |
[35, 36, 49, 57, 234 , 259, 280] |
GLS2 |
Glutaminase 2 |
+ |
Promote transcription |
Promote TCA cycle and ferroptosis |
− |
Amino acid metabolism |
[51, 52] |
ME1/2 |
Malic enzyme 1/2 |
− |
Suppress transcription |
Inhibit NADPH synthesis and lipogenesis, suppress glutaminolysis, promote senescence |
− |
|
[53] |
PC |
Pyruvate carboxylase |
+/− |
Promote or suppress transcription |
(1) Promote TCA cycle in PDAC; (2) Inhibit TCA cycle and OXPHO in pancreatic β cell and impair GSIS (glucose-stimulated insulin secretion), leading to glucose intolerance |
− |
|
[54, 69] |
IDH1 |
Isocitrate dehydrogenase 1 |
+ |
Promote transcription |
Promote TCA cycle and α-ketoglutarate generation in PDAC |
− |
|
[54] |
TET2 |
Ten-eleven translocation 2 |
+/− |
Support its function by accumulation of αKG or promote its autophagic degradation |
Promote PDAC differentiation or decrease cancer therapeutic resistance |
− |
|
[54, 366] |
SCO2 |
Synthesis of cytochrome c oxidase 2 |
+ |
Promote transcription |
Promote formation of the cytochrome c oxidase complex (complex IV) and enhance OXPHOS |
− |
|
[55] |
AIF |
Apoptosis-inducing factor |
+ |
Promote transcription |
Promote stability of the mitochondrial complex I and enhance OXPHOS |
− |
|
[56] |
DPYSL4 |
Dihydropyrimidinase-like 4 |
+ |
Promote transcription |
Promote mitochondrial supercomplexes activity and enhance OXPHOS |
− |
|
[58] |
OSCP |
Oligomycin sensitivity-conferring protein |
+ |
Bind to promote its activity |
Promotes assembly of F1F0-ATP synthase and enhance OXPHOS |
NA |
|
[59] |
RelA |
RELA protooncogene, NF-κB subunit |
− |
Bind to suppress its activity |
Promote mitochondrial gene expression and OXPHOS |
− |
|
[60] |
TFAM |
Transcription factor A, mitochondrial |
+ |
Promote transcription or bind to promote its activity |
Promote mitochondrial DNA replication and function to enhance OXPHOS |
− |
|
[61, 62] |
POLG |
Mitochondrial DNA polymerase subunit γ |
+ |
Bind to promote its activity |
Promote mitochondrial genome stability and enhance OXPHOS |
NA |
|
[63] |
HmtSSB |
Human single-stranded DNA-binding protein, mitochondrial |
+ |
Bind to promote its activity |
Promote mitochondrial genome stability and enhance OXPHOS |
NA |
|
[64] |
Tom20, Tim23, and mtHsp60/70 |
Tom20: translocase of outer membrane 20; Tim23: translocase of inner membrane 23; mtHsp60/70: mitochondrial heat shock protein 60/70 |
+ |
Promote transcription |
Promote mitochondrial normal function and enhance OXPHOS |
− |
|
[65] |
MNF2 |
Mitofusin 2 |
+ |
Promote transcription |
Promote mitochondrial fusion and enhance OXPHOS |
− |
|
[67] |
apoB and apobec1 |
apoB: apolipoprotein B; apobec1: apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
+ |
Promote transcription |
Promote APOB biogenesis and lipid transportation |
NA |
|
[72] |
PLTP, Abca12, and Cel |
PLTP: phospholipid transfer protein; Abca12: ATP binding cassette subfamily A member 12; Cel: carboxyl ester lipase |
+ |
Promote transcription |
Promote lipid transport in circulation |
NA |
|
[73] |
CYP19 |
Aromatase |
+ |
Promote transcription |
Inihibit lipid accumulation and avoid fat |
NA |
|
[74] |
SIRT1 |
NAD-dependent protein deacetylase sirtuin-1 |
+ |
Bind Foxo3a to promote its transcription |
Inhibit lipid accumulation |
NA |
|
[75, 76] |
DHRS3 |
Dehydrogenase/reductase 3 |
+ |
Promote transcription |
Promote lipid droplet formation |
NA |
|
[77] |
NPC1L1, TNF, and CCL2 |
NPC1L1: NPC1 like intracellular cholesterol transporter 1; TNF: tumor necrosis factor; CCL2: C-C motif chemokine ligand 2 |
+ |
Promote transcription |
Promote fat accumulation |
NA |
|
[78] |
SREBP-1c |
Sterol regulatory element-binding protein-1c |
− |
Suppress transcription |
Inhibit lipogenesis |
− |
|
[79] |
OPN |
Osteopontin |
+ |
Promote transcription |
Inhibit de novo lipogenesis |
NA |
|
[80] |
ADRB3 |
Adrenoceptor beta 3 |
+ |
Promote transcription |
Promote lipolysis |
+ |
|
[81] |
PANK1 |
Pantothenate kinase 1 |
+ |
Promote transcription |
Promote CoA synthesis to facilitate β-oxidation and gluconeogenesis |
NA |
Glueose metabolism |
[42] |
CROT |
Carnitine O-octanoyltransferase |
+ |
Promote transcription |
Promote transport of medium length acyl chains to the mitochondria to facilitate FAO |
NA |
|
[73, 82] |
MCD |
Malonyl-CoA decarboxylase |
+ |
Promote transcription |
Promote import long chain fatty acid into mitochondria to facilitate FAO |
− |
|
[83] |
Acad11 |
Acyl-CoA dehydrogenase family member 11 |
+ |
Promote transcription |
Promote FAO |
+ |
|
[84] |
LPIN1 |
Lpin1 |
+ |
Promote transcription |
Promote FAO |
− |
|
[85] |
CPT1C |
Carnitine palmitoyltransferase 1C |
+ |
Promote transcription |
Promote transport of long-chain fatty acids into mitochondria to facilitate FAO |
+ |
|
[86] |
PGC1α/β |
Peroxisome proliferator-activated receptor γ coactivator 1α/β |
− |
Suppress transcription |
(1) Inhibit mitochondria biogenesis to promote premature aging upon telomere attrition (2) PGC-1α directly binds p53 to promotes cell survival upon metabolic stress (3) p53 inhibits FAO by downregulating PGC1α |
NA |
|
[70, 71, 94, 322] |
APLN and APLNR |
APLN: Apelin; APLNR: Apelin receptor |
− |
Suppress transcription |
Inhibit FAO |
NA |
|
[94] |
SK1 |
Sphingosine kinase 1 |
− |
Suppress transcription |
Promote synthesis of proapoptotic ceramides and sphingosine, while inhibit synthesis of the anti-apoptotic S1P |
− |
|
[88] |
CERS6 |
Ceramide synthase 6 |
+ |
Promote transcription |
Promote synthesis of proapoptotic ceramide |
− |
|
[89] |
nSMASE2 |
Neutral sphingomyelinase 2 |
+ |
Promote transcription |
Promote synthesis of proapoptotic ceramide |
− |
|
[90] |
ACER2 |
Alkaline ceramidase 2 |
+ |
Promote transcription |
Inhibit ceramide but promote sphingosine and S1P synthesis |
−/+ |
|
[91] |
CERS5 |
Ceramide synthase 5 |
+ |
Promote transcription |
Promote synthesis of C16:0-ceramide to promote autophagy and mitochondrial respiration, and thus enhancing chemoresistance to chemotherapy |
+ |
|
[92] |
CDS1/2 |
CDP-diacylglycerol synthase 1/2 |
+ |
Promote transcription |
Promote cardiolipin de novo synthesis |
NA |
|
[93] |
Hmgcll1 |
3-hydroxymethyl-3-methylglutaryl-coA lyase like 1 |
+ |
Promote transcription |
Promote ketone bodies generation and energy production |
− |
|
[84] |
LIMA1 |
LIM domain and actin binding 1 |
+ |
Promote transcription |
Promote cholestrol uptake |
− |
|
[95, 96] |
CAV |
Caveolin 1 |
+ |
Promote transcription |
Promote cell cholesterol efflux |
+/− |
|
[97] |
SHP |
Small heterodimer partner |
+ |
Promote transcription |
Inhibit bile acid synthesis and intestinal lipid absorption |
NA |
|
[98] |
ABCC3 and CYP2B6 |
ABCC3: ATP binding cassette subfamily C member 3; CYP2B6: cytochrome P450 family 2 subfamily B member 6 |
+ |
Promote transcription |
Promote bile acid disposition and improve cholestasis |
NA |
|
[99] |
ABCA1 |
ATP binding cassette subfamily A member 1 |
+ |
Promote transcription |
Inhibit mevalonate pathway |
− |
|
[101] |
HMGCR, MVK, FDPS, and FDFT1 |
HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase; MVK: mevalonate kinase; FDPS: farnesyl diphosphate synthase; FDFT1: farnesyl-diphosphate farnesyltransferase 1 |
+ |
Promote transcription |
Promote mevalonate pathway |
NA |
|
[102] |
SOAT1 |
Sterol O-acyltransferase 1 |
− |
Suppress transcription |
Inhibit mevalonate pathway |
− |
|
[103] |
SCD1 |
Stearoyl-CoA desaturase |
− |
Suppress transcription |
Inhibit fatty acid desaturation |
− |
Cros stalk with AKT |
[105] |
Sema3E |
Semaphorin 3E |
+ |
Promote transcription |
Promote adipose tissue inflammation and insulin resistance |
NA |
|
[106, 107] |
PRDM16 |
PR/SET domain 16 |
+ |
Promote transcription |
Promote brown adipose tissue differentiation and thermogenesis |
NA |
|
[108] |
Elovl3 |
Elongation of very long chain fatty acids protein 3 |
+ |
Promote transcription |
Promote thermogenesis |
NA |
|
[109] |
Amino acid metabolism
|
SLC1A3 |
Solute carrier family 1 member 3 |
+ |
Promote transcription |
Promote aspartate uptake and cancer cell adaptation to glutamine deprivation |
+ |
Amino acid metabolism |
[113] |
SLC7A3 |
Solute carrier family 7 member 3 |
+ |
Promote transcription |
Promote arginine uptake and cancer cell adaptation to glutamine deprivation |
+ |
Amino acid metabolism |
[114] |
SLC7A11 |
Solute carrier family 7 member 11 |
− |
Suppress transcription |
Inihibit cystine uptake and promote ferroptosis |
− |
Amino acid metabolism |
[115, 116, 228] |
p21 |
CDKN1A, cyclin dependent kinase inhibitor 1A |
+ |
Promote transcription |
(1) Promote cell cycle arrest and cancer cell survival under serine/glutamine/cystine deprivation (2) stablilize NRF2 |
+/− |
Amino acid metabolism and ROS control |
[120, 121, 172, 232] |
MDM2 |
Mouse double minute 2 homolog |
+ |
Promote transcription |
(1) Promote serine metabolism and redox homeostasis; (2) promote adipocyte differentiation |
+ |
Amino acid metabolism and ROS control |
[110, 122] |
PHGDH |
Phosphoglycerate dehydrogenase |
− |
Suppress transcription |
Inhibit serine synthesis |
− |
Amino acid metabolism |
[123] |
ASS1 |
Argininosuccinate synthase 1 |
+ |
Promote transcription |
Promote arginine biosynthesis and inhibit AKT |
+ |
Amino acid metabolism and cross talk with AKT |
[124] |
ASNS |
Asparagine synthetase |
− |
Suppress transcription |
Suppress asparagine synthesis and promote senescence and cell cycle arrest |
− |
Crosstalk with AMPK |
[127] |
PW1 |
PEG3, paternally expressed gene 3 |
+ |
Promote expression |
Inhibit muscle differention and promote muscle atrophy and cachexia |
+ |
Amino acid metabolism |
[129] |
Ammonia metabolism
|
SAT1 |
Spermidine/spermine N1-acetyltransferase 1 |
+ |
Promote transcription |
Promote ALOX15 activity and ferroptosis |
− |
Ferroptosis |
[130] |
CPS1, OTC, and ARG 1 |
CPS1: carbamoylphosphate synthase 1; OTC: ornithine carbamoyltransferase; ARG1 : Arginase 1 |
− |
Suppress transcription |
Suppresse ureagenesis and ammonia elimination |
− |
Amino acid metabolism |
[131] |
Nucleotide metabolism
|
dUTPase |
DUT, deoxyuridine triphosphatase |
− |
Suppress transcription |
Inhibit dTTP biogenesis |
− |
|
[133] |
GMPS |
Guanine monophosphate synthase |
− |
Suppress transcription |
Inhibit GMP biogenesis |
− |
|
[134, 135] |
IMPDH |
Inosine monophosphate dehydrogenase |
− |
Induce miR-34a to inhibit its translation |
Inhibit GTP biogenesis |
− |
|
[136] |
RRM1/2 |
Ribonucleotide reductase catalytic subunit M1/2 |
− |
Suppress expression by inhibiting mTOR |
Inhibit nucleotide synthesis |
− |
|
[137] |
p53R2 (RRM2B) |
Ribonucleotide reductase regulatory TP53 inducible subunit M2B |
+ |
Promote transcription |
(1) Promote dNTP synthesis; (2) bind catalase to lower ROS |
−/+ |
ROS control |
[138, 139, 195] |
ADORA2B |
Adenosine A2b receptor |
+ |
Promote transcription |
Promote extracellular adenosine sensing and apoptosis |
− |
|
[144] |
Iron metabolism
|
TFR1 |
Transferrin receptor 1 |
−/+ |
Inhibit or promote expression posttranscriptionally |
Induce cell cycle arrest by reducing intracellular iron level or promote ferroptosis by increasing intracellular iron level |
− |
|
[148, 152] |
ferritin |
ferritin |
+ |
Promote expression posttranscriptionally |
Induce cell cycle arrest by reducing the labile iron level |
− |
|
[148] |
ZIP14 (SLC39A14) |
Zrt- and Irt-like protein 14 (solute carrier family 39 member 14) |
− |
Bind to promote its ubiquitin-mediated degradation |
Inhibit iron uptake |
− |
|
[149, 150] |
HAMP |
Hepcidin antimicrobial peptide |
+ |
Promote transcription |
Reduce serum iron and induce iron sequestration in the reticuloendothelial macrophages |
− |
|
[151] |
ISCU |
Iron-sulfur cluster assembly enzyme |
+ |
Promote transcription |
Promote Fe-S cluster biogenesis to reduce labile iron level and ROS |
− |
ROS control |
[153] |
FXN |
Frataxin |
+ |
Promote transcription |
Promote Fe-S cluster biogenesis to reduce labile iron level and ROS |
− |
|
[154, 155] |
FDXR |
Ferredoxin reductase |
+ |
Promote transcription |
Promote Fe-S cluster biogenesis to reduce labile iron level and ROS |
− |
ROS control |
[156, 157] |
SLC25A28 |
Solute carrier family 25 member 28 |
+ |
Binds to promote its activity |
Promote abnormal accumulation of mitochondrial iron and ferroptosis |
NA |
|
[158] |
ROS control
|
NRF2 |
NFE2L2, nuclear factor, erythroid 2 like 2 |
+/− |
Promote its stabilization by inducing p21 or suppress its transcription by inhibiting Sp1 |
Lower or enhance ROS |
+/− |
|
[172, 176, 183, 339] |
SESN1 (PA26) |
Sestrin 1 (p53 activated gene 26) |
+ |
Promote transcription |
Lower ROS |
− |
Crosstalk with AMPK |
[173, 175, 193, 273] |
SESN2 (Hi95) |
Sestrin 2 (hypoxia induced gene 95) |
+ |
Promote transcription |
Lower ROS |
−/+ |
Crosstalk with AMPK |
[174, 175, 193, 273] |
PML |
PML nuclear body scaffold |
+ |
Promote transcription |
Function as a ROS sensor to activate p53 |
− |
|
[184–186] |
COX-2 |
PTGS2, prostaglandin-endoperoxide synthase 2 |
−/+ |
Suppress or promote expression |
Enhance or lower ROS |
−/+ |
|
[187, 188] |
NOS2 |
Nitric oxide synthase 2 |
− |
Suppress transcription |
Lower ROS |
− |
|
[187] |
NOS3 (eNOS) |
Nitric oxide synthase 3 (Endothelial NOS) |
+/− |
Promote or suppress transcription |
(1) Protect cardiomyocytes from ischemia/ref low-induced death; (2) Protect organism from dietary obesity |
NA |
|
[21, 189] |
NOX4 |
NADPH oxidase 4 |
− |
Suppress expression |
Lower ROS and cell metastasis |
− |
|
[190] |
Mieap (SPATA18) |
Mitochondria-eating protein (spermatogenesis associated 18) |
+ |
Promote transcription |
Promote repair or degradation of unhealthy mitochondria and lower ROS |
NA |
OXP HOS |
[66] |
CAT |
Catalase |
+/− |
Promote transcription or suppress activity |
Lower or enhance ROS |
NA |
|
[191, 195] |
GPX1 |
Glutathione peroxidase 1 |
+ |
Promote transcription |
Lower ROS (may enhance ROS and apoptosis in specific circumstances) |
− |
|
[192] |
MnSOD (SOD2) |
Manganese superoxide dismutase (superoxide dismutase 2) |
+/− |
Promote or inhibit transcription or directly bind to suppress its activity or destablize protein |
Lower or enhance ROS |
− |
|
[192, 196–198] |
HO-1 (HMOX1) |
Heme oxygenase-1 |
+/− |
Promote transcription or destablize protein |
Lower or enhance ROS |
NA |
|
[194, 198, 199] |
ALDH4 |
ALDH4A1, aldehyde dehydrogenase 4 family member A1 |
+ |
Promote transcription |
Lower ROS |
NA |
Amino acid metabolism |
[126] |
SLC2A9 (GLUT9) |
Solute carrier family 2 member 9 (glucose transporter 9) |
+ |
Promote transcription |
Promote transport uric acid into cell to lower ROS |
− |
Uric acid metabolism |
[132] |
TP53INP1 |
Tp53-inducible nuclear protein 1 |
+ |
Promote transcription |
Lower ROS or promote autophagy-dependent cell death |
− |
Autophagy |
[200, 263] |
PUMA |
p53 up-regulated modulator of apoptosis |
+ |
Promote transcription |
Ehance ROS or suppress mitochondrial pyruvate uptake by inactivating MPC, thus suppressing OXPHOS |
−/+ |
OXP HOS |
[68, 201, 202] |
BAX |
BCL2-associated X protein |
+ |
Promote transcription |
Ehance ROS |
− |
|
[203, 204] |
Noxa |
PMAIP1: phorbol-12-myristate-13-acetate-induced protein 1 |
+ |
Promote transcription |
Ehance ROS |
− |
|
[205, 206] |
NCF2/p67p hox |
Neutrophil cytosolic factor 2 |
+ |
Promote transcription |
Ehance ROS |
+ |
|
[208] |
p66Shc |
SHC1: SHC adaptor protein 1 |
+ |
Promote transcription |
Ehance ROS |
− |
|
[209] |
PIG1 (Galectin-7/LGALS7) |
p53-induced gene 1 (lectin, galactoside-binding, soluble, 7) |
+ |
Promote transcription |
Enhance ROS |
− |
|
[210, 211] |
PIG3 (TP53I3) |
p53-induced gene 3 (tumor protein p53 inducible protein 3) |
+ |
Promote transcription |
Enhance ROS |
− |
|
[195, 210] |
PIG6 (PRODH/POX) |
p53-induced gene 6 (proline dehydrogenase 1/proline oxidase) |
+ |
Promote transcription |
Catalyze proline dehydrogenation and enhance ROS |
− |
Amino acid metabolism |
[125, 210] |
NQO1 and GST-α1 |
NQO1: NAD(P)H quinone dehydrogenase 1; GST-α1: glutathione S-transferase α1 |
− |
Suppress transcription by inhibiting NRF2 |
Ehance ROS |
− |
|
[115] |
DRP1 |
DNM1L: dynamin 1 like |
+ |
Bind to promote its activity |
Promote mitochondria fragmentation and dysfunction, and enhance mitochondrial ROS |
NA |
|
[212] |
Opa1 |
OPA1 mitochondrial dynamin like GTPase |
+ |
Bind prohibitin 1 (PHB1) to release Opa1 |
Promote mitochondria fragmentation (enhance ROS) and apoptosis |
− |
|
[213] |
cyclophilin D (CypD) |
PPIF: peptidylprolyl isomerase F |
+ |
Bind to promote its activity |
Promote mitochondrial permeability transition pore (PTP) opening (enhance ROS) and necrosis |
− |
|
[214] |
CTSQ |
cathepsin Q |
+ |
Promote transcription |
Promote necrosis along with ROS |
− |
|
[215] |
Ferroptosis
|
CBS |
Cystathionine β-synthase |
− |
Suppress expression posttranscriptionally |
Promote ferroptosis |
− |
Amino acid metabolism |
[119] |
DPP4 |
Dipeptidyl peptidase 4 |
− |
Bind to inhibit its activity |
Inhibit ferroptosis |
+ |
ROS control |
[233] |
Autophagy
|
ATG2B/4A/4C/7/10, UVRAG, and VMP1(TME M49) |
ATG2B/4A/4C/7/10: autophagy related 2B/4A/4C/7/10 ;UVRAG: UV radiation resistance associated; VMP1(TMEM4 9): vacuole membrane protein 1 (transmembrane protein 49) |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[239] |
ULK1/2 |
Unc-51 like autophagy activating kinase 1/2 |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[239, 241] |
DRAM |
Damage-regulated autophagy modulator |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[243] |
CTSD |
Cathepsin D |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[244–247] |
ISG20L1 (AEN) |
Interferon stimulated exonuclease gene 20kDa-like 1 (apoptosis enhancing nuclease) |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[248] |
Dapk1 |
Death associated protein kinase 1 |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[249] |
PIG8 (EI24) |
p53-induced gene 8 (EI24 autophagy associated transmembrane protein) |
+ |
Promote transcription |
Promote autophagy and cell death |
− |
|
[250] |
TGM2 |
Transglutaminase 2 |
+ |
Promote transcription |
Promote autophagy |
− |
|
[251] |
BNIP3 |
BCL2 interacting protein 3 |
+/− |
Promote or inhibit transcription |
Promote mitophagy or suppress hypoxia-induced apoptosis |
+ |
|
[253, 254] |
BNIP3L (NIX) |
BCL2 interacting protein 3 like (NIP-3-like protein X) |
+ |
Promote transcription |
Promote mitophagy and cell death |
− |
|
[255, 256] |
HMGB1 |
High mobility group box 1 |
− |
Bind to inhibit its activity |
Inhibit autophagy |
+ |
|
[257] |
LC3 |
MAP1LC3A, microtubule associated protein 1 light chain 3 alpha |
−/+ |
Inhibit expression posttranscriptionally or induce TP53INP 1 to bind and promote its activity |
Inhibit or promote autophagy |
+/− |
|
[262, 263] |
RB1CC1 (FIP200) |
RB1 inducible coiled-coil 1 (FAK family kinase-interacting protein of 200 KDa) |
− |
Bind to inhibit its activity |
Inhibit autophagy |
NA |
|
[264] |
Crosstalk with metabolic sensors
|
AMPKβ1/2 and TSC2 |
AMPKβ1/2: protein kinase AMP-activated non-catalytic subunit α2/β2; TSC2: tuberous sclerosis complex 2 |
+ |
Promote transcription |
Activate AMPK but repress mTOR pathway |
− |
|
[271] |
LKB1 |
Liver kinase B1 |
+ |
Promote transcription |
Activate AMPK pathway |
− |
|
[272] |
IGF1R |
Insulin like growth factor 1 receptor |
− |
Suppress transcription |
Repress AKT pathway |
− |
|
[275, 276] |
IGFBP3 |
Insulin like growth factor binding protein 3 |
+ |
Promote transcription |
Repress AKT pathway |
− |
|
[277] |
IGFBP1 |
Insulin like growth factor binding protein 1 |
+ |
Promote transcription |
Inhibit apoptosis |
+ |
|
[278] |
PTEN |
Phosphatase and tensin homolog |
+ |
Promote transcription |
Repress AKT and mTOR pathway |
− |
|
[271, 279] |
PLK1 |
Polo-like kinase 1 |
− |
Suppress transcription |
Repress AKT pathway |
− |
|
[281–283] |
PLK2 |
Polo-like kinase 2 |
+ |
Promote transcription |
Repress mTOR pathway |
− |
|
[284, 285] |
REDD1 |
DDIT4: DNA damage inducible transcript 4 |
+ |
Promote transcription |
Repress mTOR pathway |
− |
|
[286–289] |
PHLDA1/3 |
Pleckstrin homology like domain family A member 1/3 |
+ |
Promote transcription |
Repress AKT pathway |
− |
|
[290–292] |
SIVA |
SIVA1: SIVA1 apoptosis inducing factor |
+ |
Promote transcription |
Promote mTOR pathway |
+ |
|
[293–295] |
Drug metabolism
|
CYPs, SULTs, and MRPs |
CYPs: cytochromes P450 family; SULTs: sulfotransferase family; MRPs: multidrug resistance-associated protein family |
+ |
Promote transcription |
Promote metabolism of drugs, carcinogens, and pollutants |
NA |
|
[392–396] |